Lymphoma

CLINICAL_TRIALS trial_result · 2026-03-02

Clinical Trial Update: A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients [Phase 1]

Phase 1 study evaluating PN20 to prevent chemotherapy-induced thrombocytopenia in patients with lymphoma or solid tumors; the trial has comp…

CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: HeartPhone Cancer Survivors Trial 2019 [Phase 1, Phase 2]

The HeartPhone Cancer Survivors Trial (Phase 1/2) sponsored by Penn State University was terminated; results have been posted for breast can…

CLINICAL_TRIALS trial_result · 2026-02-25

Clinical Trial Update: Virtual Rehabilitation for Cancer Survivors [NA]

A clinical trial update indicates a virtual rehabilitation program for cancer survivors is currently recruiting across multiple cancer types…

CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma [Phase 1, Phase 2]

This entry reports a Phase 1/2 clinical trial evaluating CBL0137 for relapsed or refractory solid tumors, including central nervous system t…

CLINICAL_TRIALS other · 2026-02-24

Clinical Trial Update: UPLYFT For Lymphoma Survivors [NA]

Clinical trial is recruiting to evaluate UPLYFT for lymphoma survivors.

CLINICAL_TRIALS trial_result · 2026-02-20

Clinical Trial Update: Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]

A Phase 2 trial of pembrolizumab in PD-L1–expressing Diffuse Large B-Cell Lymphoma was terminated, and results were posted on February 20, 2…

CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma [Phase 2]

BRAZAN is a Phase 2 randomized trial evaluating induction with Bendamustine, Rituximab, Cytarabine plus Zanubrutinib, followed by Zanubrutin…

CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL [Phase 1]

A Phase 1 study evaluating pembrolizumab in combination with chemotherapy for newly diagnosed Primary Central Nervous System Lymphoma is cur…

CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care [NA]

This clinical trial update describes a University of Miami-sponsored study evaluating how Leukemia & Lymphoma Society services affect patien…

CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy [Phase 2]

A Phase 2 clinical trial evaluating the safety and pharmacokinetics of eflapegrastim in pediatric patients with solid tumors or lymphoma und…

CLINICAL_TRIALS trial_result · 2026-02-18

Clinical Trial Update: Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults [EARLY_Phase 1]

A Phase 1 trial evaluating pembrolizumab in combination with decitabine and hypofractionated radiation in pediatric and young adult patients…

CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma [Phase 1, Phase 2]

This is a pediatric and young adult Phase 1/2 clinical trial evaluating a CD22-directed CAR-T cell therapy for relapsed or refractory leukem…

CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers

The study investigates cachexia frequency in ambulatory cancer patients and the psychological burden on patients and their primary caregiver…

CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: National Longitudinal Cohort of Hematological Diseases

Recruiting for a national longitudinal cohort study of hematological diseases sponsored by the Institute of Hematology & Blood Diseases Hosp…

CLINICAL_TRIALS trial_result · 2026-02-11

Clinical Trial Update: Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma [Phase 1]

A Phase 1 trial of CUDC-907 (fimepinostat) in children and young adults with relapsed or refractory solid tumors, CNS tumors, or lymphoma ha…

CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer [Phase 2]

Phase 2 clinical trial comparing GEO-CM04S1 vaccine to an mRNA SARS-CoV-2 vaccine in patients with hematologic malignancies; the study is cu…

CLINICAL_TRIALS trial_result · 2026-02-09

Clinical Trial Update: Cardiovascular Effects of CART Cell Therapy

A completed clinical trial update investigates the cardiovascular effects of CAR-T cell therapy in leukemia and lymphoma patients.

CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: Pediatric PET/MR Image Registry

A pediatric PET/MR image registry is currently recruiting to collect imaging data for soft tissue sarcoma, lymphoma, and osteosarcoma.

CLINICAL_TRIALS trial_result · 2026-02-06

Clinical Trial Update: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas [Phase 1]

Phase 1 study evaluating CD45RA+ depleted haploidentical stem cell transplantation in children with relapsed or refractory solid tumors and …